These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 19283670)
21. Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury. Jarocha D; Milczarek O; Wedrychowicz A; Kwiatkowski S; Majka M Cell Transplant; 2015; 24(4):661-72. PubMed ID: 25807231 [TBL] [Abstract][Full Text] [Related]
22. Effects of magnetic nanoparticle-incorporated human bone marrow-derived mesenchymal stem cells exposed to pulsed electromagnetic fields on injured rat spinal cord. Cho H; Choi YK; Lee DH; Park HJ; Seo YK; Jung H; Kim SC; Kim SM; Park JK Biotechnol Appl Biochem; 2013; 60(6):596-602. PubMed ID: 24033637 [TBL] [Abstract][Full Text] [Related]
24. A Comparative Study of the Therapeutic Potential of Mesenchymal Stem Cells and Limbal Epithelial Stem Cells for Ocular Surface Reconstruction. Holan V; Trosan P; Cejka C; Javorkova E; Zajicova A; Hermankova B; Chudickova M; Cejkova J Stem Cells Transl Med; 2015 Sep; 4(9):1052-63. PubMed ID: 26185258 [TBL] [Abstract][Full Text] [Related]
25. Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells. Barzilay R; Ben-Zur T; Bulvik S; Melamed E; Offen D Stem Cells Dev; 2009 May; 18(4):591-601. PubMed ID: 19298173 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation. Kim JW; Ha KY; Molon JN; Kim YH Spine (Phila Pa 1976); 2013 Aug; 38(17):E1065-74. PubMed ID: 23629485 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry. Wei CC; Lin AB; Hung SC Cell Transplant; 2014; 23(4-5):505-12. PubMed ID: 24816447 [TBL] [Abstract][Full Text] [Related]
28. Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage. Gang EJ; Bosnakovski D; Simsek T; To K; Perlingeiro RC Exp Cell Res; 2008 May; 314(8):1721-33. PubMed ID: 18395202 [TBL] [Abstract][Full Text] [Related]
29. Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation. Karaoz E; Kabatas S; Duruksu G; Okcu A; Subasi C; Ay B; Musluman M; Civelek E Turk Neurosurg; 2012; 22(2):207-17. PubMed ID: 22437296 [TBL] [Abstract][Full Text] [Related]
30. Restorative benefits of transplanting human mesenchymal stromal cells overexpressing arginine decarboxylase genes after spinal cord injury. Park YM; Han SH; Seo SK; Park KA; Lee WT; Lee JE Cytotherapy; 2015 Jan; 17(1):25-37. PubMed ID: 25442787 [TBL] [Abstract][Full Text] [Related]
31. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease. Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216 [TBL] [Abstract][Full Text] [Related]
32. Human adipose-derived mesenchymal stem cells: a better cell source for nervous system regeneration. Han C; Zhang L; Song L; Liu Y; Zou W; Piao H; Liu J Chin Med J (Engl); 2014; 127(2):329-37. PubMed ID: 24438624 [TBL] [Abstract][Full Text] [Related]
33. [Cutaneous mesenchymal stem cells. Current status of research and potential clinical applications]. Sellheyer K; Krahl D Hautarzt; 2010 May; 61(5):429-34. PubMed ID: 20221573 [TBL] [Abstract][Full Text] [Related]
34. Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord rats. Alexanian AR; Kwok WM; Pravdic D; Maiman DJ; Fehlings MG Restor Neurol Neurosci; 2010; 28(6):761-7. PubMed ID: 21209491 [TBL] [Abstract][Full Text] [Related]
35. Human mesenchymal precursor cells (Stro-1⁺) from spinal cord injury patients improve functional recovery and tissue sparing in an acute spinal cord injury rat model. Hodgetts SI; Simmons PJ; Plant GW Cell Transplant; 2013; 22(3):393-412. PubMed ID: 23007022 [TBL] [Abstract][Full Text] [Related]
36. Combination of activated Schwann cells with bone mesenchymal stem cells: the best cell strategy for repair after spinal cord injury in rats. Ban DX; Ning GZ; Feng SQ; Wang Y; Zhou XH; Liu Y; Chen JT Regen Med; 2011 Nov; 6(6):707-20. PubMed ID: 22050523 [TBL] [Abstract][Full Text] [Related]
37. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Kan I; Melamed E; Offen D Handb Exp Pharmacol; 2007; (180):219-42. PubMed ID: 17554511 [TBL] [Abstract][Full Text] [Related]
38. [The use of mesenchymal stromal cells in oncology and cell therapy]. Pommey S; Galipeau J Bull Cancer; 2006 Sep; 93(9):901-7. PubMed ID: 16980233 [TBL] [Abstract][Full Text] [Related]
39. Comparison of functional and histological outcomes after intralesional, intracisternal, and intravenous transplantation of human bone marrow-derived mesenchymal stromal cells in a rat model of spinal cord injury. Shin DA; Kim JM; Kim HI; Yi S; Ha Y; Yoon DH; Kim KN Acta Neurochir (Wien); 2013 Oct; 155(10):1943-50. PubMed ID: 23821338 [TBL] [Abstract][Full Text] [Related]
40. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. Hayase M; Kitada M; Wakao S; Itokazu Y; Nozaki K; Hashimoto N; Takagi Y; Dezawa M J Cereb Blood Flow Metab; 2009 Aug; 29(8):1409-20. PubMed ID: 19436312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]